短腸症候群（SBS）治療薬の世界市場（～2026年）

• 英文タイトル：Global Short Bowel Syndrome (SBS) Drugs Market Insights and Forecast to 2026

• レポートコード：MRC2-11QY09456 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、112ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ
Enterprise License	￥1,154,400 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当調査資料は短腸症候群（SBS）治療薬のグローバル市場について調査・分析したレポートです。種類別（グルカゴン様ペプチド-2（GLP-2）、成長ホルモン、グルタミン、その他）市場規模、用途別（病院、診療所、小売薬局）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別短腸症候群（SBS）治療薬の競争状況、市場シェア ・世界の短腸症候群（SBS）治療薬市場：種類別市場規模 2015年-2020年（グルカゴン様ペプチド-2（GLP-2）、成長ホルモン、グルタミン、その他） ・世界の短腸症候群（SBS）治療薬市場：種類別市場規模予測 2021年-2026年（グルカゴン様ペプチド-2（GLP-2）、成長ホルモン、グルタミン、その他） ・世界の短腸症候群（SBS）治療薬市場：用途別市場規模 2015年-2020年（病院、診療所、小売薬局） ・世界の短腸症候群（SBS）治療薬市場：用途別市場規模予測 2021年-2026年（病院、診療所、小売薬局） ・北米の短腸症候群（SBS）治療薬市場分析：米国、カナダ ・ヨーロッパの短腸症候群（SBS）治療薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの短腸症候群（SBS）治療薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の短腸症候群（SBS）治療薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの短腸症候群（SBS）治療薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Merck、Takeda、Emmaus Medical、Ardelyx、Naia Pharmaceuticals、Nutrinia、OxThera、Sancilio Pharmaceuticals、Zealand Pharma ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論

Short bowel syndrome (SBS) is a metabolic disorder occurs when the portion of the small intestine is not functioning or removed through surgery due to digestive illness. SBS is caused by lack of function of the small intestine. This results in malabsorption, diarrhea, steatorrhea, fluid and electrolyte disturbances, and malnutrition.
During 2017, the parental route segment accounted for the major shares and dominated the SBS market. Factors such as the rapid action mechanism of the drug and the prolonged action result contribute to the growth of this market segment in the coming years. In the parental route, the drug is administered intravenously, subcutaneously, intrathecally, or through intramuscular routes and is applied when the oral route of drug administration is ineffective.

Market Analysis and Insights: Global Short Bowel Syndrome (SBS) Drugs Market
The global Short Bowel Syndrome (SBS) Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Short Bowel Syndrome (SBS) Drugs Scope and Market Size
Short Bowel Syndrome (SBS) Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Short Bowel Syndrome (SBS) Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Short Bowel Syndrome (SBS) Drugs market is segmented into
Glucagon-Like Peptide-2 (GLP-2)
Growth Hormone
Glutamine
Other

Segment by Application, the Short Bowel Syndrome (SBS) Drugs market is segmented into
Hospitals
Clinics
Retail Pharmacies

Regional and Country-level Analysis
The Short Bowel Syndrome (SBS) Drugs market is analysed and market size information is provided by regions (countries).
The key regions covered in the Short Bowel Syndrome (SBS) Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Short Bowel Syndrome (SBS) Drugs Market Share Analysis
Short Bowel Syndrome (SBS) Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Short Bowel Syndrome (SBS) Drugs business, the date to enter into the Short Bowel Syndrome (SBS) Drugs market, Short Bowel Syndrome (SBS) Drugs product introduction, recent developments, etc.

The major vendors covered:
Merck
Takeda
Emmaus Medical
Ardelyx
Naia Pharmaceuticals
Nutrinia
OxThera
Sancilio Pharmaceuticals
Zealand Pharma

レポート目次

---

1 Study Coverage
1.1 Short Bowel Syndrome (SBS) Drugs Product Introduction
1.2 Market Segments
1.3 Key Short Bowel Syndrome (SBS) Drugs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Short Bowel Syndrome (SBS) Drugs Market Size Growth Rate by Type
1.4.2 Glucagon-Like Peptide-2 (GLP-2)
1.4.3 Growth Hormone
1.4.4 Glutamine
1.4.5 Other
1.5 Market by Application
1.5.1 Global Short Bowel Syndrome (SBS) Drugs Market Size Growth Rate by Application
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Retail Pharmacies
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Short Bowel Syndrome (SBS) Drugs Market Size, Estimates and Forecasts
2.1.1 Global Short Bowel Syndrome (SBS) Drugs Revenue 2015-2026
2.1.2 Global Short Bowel Syndrome (SBS) Drugs Sales 2015-2026
2.2 Global Short Bowel Syndrome (SBS) Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Short Bowel Syndrome (SBS) Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Short Bowel Syndrome (SBS) Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Short Bowel Syndrome (SBS) Drugs Competitor Landscape by Players
3.1 Short Bowel Syndrome (SBS) Drugs Sales by Manufacturers
3.1.1 Short Bowel Syndrome (SBS) Drugs Sales by Manufacturers (2015-2020)
3.1.2 Short Bowel Syndrome (SBS) Drugs Sales Market Share by Manufacturers (2015-2020)
3.2 Short Bowel Syndrome (SBS) Drugs Revenue by Manufacturers
3.2.1 Short Bowel Syndrome (SBS) Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Short Bowel Syndrome (SBS) Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Short Bowel Syndrome (SBS) Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Short Bowel Syndrome (SBS) Drugs Revenue in 2019
3.2.5 Global Short Bowel Syndrome (SBS) Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Short Bowel Syndrome (SBS) Drugs Price by Manufacturers
3.4 Short Bowel Syndrome (SBS) Drugs Manufacturing Base Distribution, Product Types
3.4.1 Short Bowel Syndrome (SBS) Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Short Bowel Syndrome (SBS) Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Short Bowel Syndrome (SBS) Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Short Bowel Syndrome (SBS) Drugs Market Size by Type (2015-2020)
4.1.1 Global Short Bowel Syndrome (SBS) Drugs Sales by Type (2015-2020)
4.1.2 Global Short Bowel Syndrome (SBS) Drugs Revenue by Type (2015-2020)
4.1.3 Short Bowel Syndrome (SBS) Drugs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Short Bowel Syndrome (SBS) Drugs Market Size Forecast by Type (2021-2026)
4.2.1 Global Short Bowel Syndrome (SBS) Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Short Bowel Syndrome (SBS) Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Short Bowel Syndrome (SBS) Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Short Bowel Syndrome (SBS) Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
5.1 Global Short Bowel Syndrome (SBS) Drugs Market Size by Application (2015-2020)
5.1.1 Global Short Bowel Syndrome (SBS) Drugs Sales by Application (2015-2020)
5.1.2 Global Short Bowel Syndrome (SBS) Drugs Revenue by Application (2015-2020)
5.1.3 Short Bowel Syndrome (SBS) Drugs Price by Application (2015-2020)
5.2 Short Bowel Syndrome (SBS) Drugs Market Size Forecast by Application (2021-2026)
5.2.1 Global Short Bowel Syndrome (SBS) Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Short Bowel Syndrome (SBS) Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Short Bowel Syndrome (SBS) Drugs Price Forecast by Application (2021-2026)

6 North America
6.1 North America Short Bowel Syndrome (SBS) Drugs by Country
6.1.1 North America Short Bowel Syndrome (SBS) Drugs Sales by Country
6.1.2 North America Short Bowel Syndrome (SBS) Drugs Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Short Bowel Syndrome (SBS) Drugs Market Facts & Figures by Type
6.3 North America Short Bowel Syndrome (SBS) Drugs Market Facts & Figures by Application

7 Europe
7.1 Europe Short Bowel Syndrome (SBS) Drugs by Country
7.1.1 Europe Short Bowel Syndrome (SBS) Drugs Sales by Country
7.1.2 Europe Short Bowel Syndrome (SBS) Drugs Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Short Bowel Syndrome (SBS) Drugs Market Facts & Figures by Type
7.3 Europe Short Bowel Syndrome (SBS) Drugs Market Facts & Figures by Application

8 Asia Pacific
8.1 Asia Pacific Short Bowel Syndrome (SBS) Drugs by Region
8.1.1 Asia Pacific Short Bowel Syndrome (SBS) Drugs Sales by Region
8.1.2 Asia Pacific Short Bowel Syndrome (SBS) Drugs Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Short Bowel Syndrome (SBS) Drugs Market Facts & Figures by Type
8.3 Asia Pacific Short Bowel Syndrome (SBS) Drugs Market Facts & Figures by Application

9 Latin America
9.1 Latin America Short Bowel Syndrome (SBS) Drugs by Country
9.1.1 Latin America Short Bowel Syndrome (SBS) Drugs Sales by Country
9.1.2 Latin America Short Bowel Syndrome (SBS) Drugs Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Short Bowel Syndrome (SBS) Drugs Market Facts & Figures by Type
9.3 Central & South America Short Bowel Syndrome (SBS) Drugs Market Facts & Figures by Application

10 Middle East and Africa
10.1 Middle East and Africa Short Bowel Syndrome (SBS) Drugs by Country
10.1.1 Middle East and Africa Short Bowel Syndrome (SBS) Drugs Sales by Country
10.1.2 Middle East and Africa Short Bowel Syndrome (SBS) Drugs Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Short Bowel Syndrome (SBS) Drugs Market Facts & Figures by Type
10.3 Middle East and Africa Short Bowel Syndrome (SBS) Drugs Market Facts & Figures by Application

11 Company Profiles
11.1 Merck
11.1.1 Merck Corporation Information
11.1.2 Merck Description and Business Overview
11.1.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Merck Short Bowel Syndrome (SBS) Drugs Products Offered
11.1.5 Merck Related Developments
11.2 Takeda
11.2.1 Takeda Corporation Information
11.2.2 Takeda Description and Business Overview
11.2.3 Takeda Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Takeda Short Bowel Syndrome (SBS) Drugs Products Offered
11.2.5 Takeda Related Developments
11.3 Emmaus Medical
11.3.1 Emmaus Medical Corporation Information
11.3.2 Emmaus Medical Description and Business Overview
11.3.3 Emmaus Medical Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Emmaus Medical Short Bowel Syndrome (SBS) Drugs Products Offered
11.3.5 Emmaus Medical Related Developments
11.4 Ardelyx
11.4.1 Ardelyx Corporation Information
11.4.2 Ardelyx Description and Business Overview
11.4.3 Ardelyx Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Ardelyx Short Bowel Syndrome (SBS) Drugs Products Offered
11.4.5 Ardelyx Related Developments
11.5 Naia Pharmaceuticals
11.5.1 Naia Pharmaceuticals Corporation Information
11.5.2 Naia Pharmaceuticals Description and Business Overview
11.5.3 Naia Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Naia Pharmaceuticals Short Bowel Syndrome (SBS) Drugs Products Offered
11.5.5 Naia Pharmaceuticals Related Developments
11.6 Nutrinia
11.6.1 Nutrinia Corporation Information
11.6.2 Nutrinia Description and Business Overview
11.6.3 Nutrinia Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Nutrinia Short Bowel Syndrome (SBS) Drugs Products Offered
11.6.5 Nutrinia Related Developments
11.7 OxThera
11.7.1 OxThera Corporation Information
11.7.2 OxThera Description and Business Overview
11.7.3 OxThera Sales, Revenue and Gross Margin (2015-2020)
11.7.4 OxThera Short Bowel Syndrome (SBS) Drugs Products Offered
11.7.5 OxThera Related Developments
11.8 Sancilio Pharmaceuticals
11.8.1 Sancilio Pharmaceuticals Corporation Information
11.8.2 Sancilio Pharmaceuticals Description and Business Overview
11.8.3 Sancilio Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Sancilio Pharmaceuticals Short Bowel Syndrome (SBS) Drugs Products Offered
11.8.5 Sancilio Pharmaceuticals Related Developments
11.9 Zealand Pharma
11.9.1 Zealand Pharma Corporation Information
11.9.2 Zealand Pharma Description and Business Overview
11.9.3 Zealand Pharma Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Zealand Pharma Short Bowel Syndrome (SBS) Drugs Products Offered
11.9.5 Zealand Pharma Related Developments
11.1 Merck
11.1.1 Merck Corporation Information
11.1.2 Merck Description and Business Overview
11.1.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Merck Short Bowel Syndrome (SBS) Drugs Products Offered
11.1.5 Merck Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Short Bowel Syndrome (SBS) Drugs Market Estimates and Projections by Region
12.1.1 Global Short Bowel Syndrome (SBS) Drugs Sales Forecast by Regions 2021-2026
12.1.2 Global Short Bowel Syndrome (SBS) Drugs Revenue Forecast by Regions 2021-2026
12.2 North America Short Bowel Syndrome (SBS) Drugs Market Size Forecast (2021-2026)
12.2.1 North America: Short Bowel Syndrome (SBS) Drugs Sales Forecast (2021-2026)
12.2.2 North America: Short Bowel Syndrome (SBS) Drugs Revenue Forecast (2021-2026)
12.2.3 North America: Short Bowel Syndrome (SBS) Drugs Market Size Forecast by Country (2021-2026)
12.3 Europe Short Bowel Syndrome (SBS) Drugs Market Size Forecast (2021-2026)
12.3.1 Europe: Short Bowel Syndrome (SBS) Drugs Sales Forecast (2021-2026)
12.3.2 Europe: Short Bowel Syndrome (SBS) Drugs Revenue Forecast (2021-2026)
12.3.3 Europe: Short Bowel Syndrome (SBS) Drugs Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Short Bowel Syndrome (SBS) Drugs Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Short Bowel Syndrome (SBS) Drugs Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Short Bowel Syndrome (SBS) Drugs Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Short Bowel Syndrome (SBS) Drugs Market Size Forecast by Region (2021-2026)
12.5 Latin America Short Bowel Syndrome (SBS) Drugs Market Size Forecast (2021-2026)
12.5.1 Latin America: Short Bowel Syndrome (SBS) Drugs Sales Forecast (2021-2026)
12.5.2 Latin America: Short Bowel Syndrome (SBS) Drugs Revenue Forecast (2021-2026)
12.5.3 Latin America: Short Bowel Syndrome (SBS) Drugs Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Short Bowel Syndrome (SBS) Drugs Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Short Bowel Syndrome (SBS) Drugs Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Short Bowel Syndrome (SBS) Drugs Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Short Bowel Syndrome (SBS) Drugs Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Short Bowel Syndrome (SBS) Drugs Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Short Bowel Syndrome (SBS) Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables
Table 1. Short Bowel Syndrome (SBS) Drugs Market Segments
Table 2. Ranking of Global Top Short Bowel Syndrome (SBS) Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Short Bowel Syndrome (SBS) Drugs Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of Glucagon-Like Peptide-2 (GLP-2)
Table 5. Major Manufacturers of Growth Hormone
Table 6. Major Manufacturers of Glutamine
Table 7. Major Manufacturers of Other
Table 8. Global Short Bowel Syndrome (SBS) Drugs Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 9. Global Short Bowel Syndrome (SBS) Drugs Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 10. Global Short Bowel Syndrome (SBS) Drugs Sales by Regions 2015-2020 (K Pcs)
Table 11. Global Short Bowel Syndrome (SBS) Drugs Sales Market Share by Regions (2015-2020)
Table 12. Global Short Bowel Syndrome (SBS) Drugs Revenue by Regions 2015-2020 (US$ Million)
Table 13. Global Short Bowel Syndrome (SBS) Drugs Sales by Manufacturers (2015-2020) (K Pcs)
Table 14. Global Short Bowel Syndrome (SBS) Drugs Sales Share by Manufacturers (2015-2020)
Table 15. Global Short Bowel Syndrome (SBS) Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 16. Global Short Bowel Syndrome (SBS) Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Short Bowel Syndrome (SBS) Drugs as of 2019)
Table 17. Short Bowel Syndrome (SBS) Drugs Revenue by Manufacturers (2015-2020) (US$ Million)
Table 18. Short Bowel Syndrome (SBS) Drugs Revenue Share by Manufacturers (2015-2020)
Table 19. Key Manufacturers Short Bowel Syndrome (SBS) Drugs Price (2015-2020) (USD/Pcs)
Table 20. Short Bowel Syndrome (SBS) Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 21. Manufacturers Short Bowel Syndrome (SBS) Drugs Product Type
Table 22. Date of International Manufacturers Enter into Short Bowel Syndrome (SBS) Drugs Market
Table 23. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 24. Global Short Bowel Syndrome (SBS) Drugs Sales by Type (2015-2020) (K Pcs)
Table 25. Global Short Bowel Syndrome (SBS) Drugs Sales Share by Type (2015-2020)
Table 26. Global Short Bowel Syndrome (SBS) Drugs Revenue by Type (2015-2020) (US$ Million)
Table 27. Global Short Bowel Syndrome (SBS) Drugs Revenue Share by Type (2015-2020)
Table 28. Short Bowel Syndrome (SBS) Drugs Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 29. Global Short Bowel Syndrome (SBS) Drugs Sales by Application (2015-2020) (K Pcs)
Table 30. Global Short Bowel Syndrome (SBS) Drugs Sales Share by Application (2015-2020)
Table 31. North America Short Bowel Syndrome (SBS) Drugs Sales by Country (2015-2020) (K Pcs)
Table 32. North America Short Bowel Syndrome (SBS) Drugs Sales Market Share by Country (2015-2020)
Table 33. North America Short Bowel Syndrome (SBS) Drugs Revenue by Country (2015-2020) (US$ Million)
Table 34. North America Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Country (2015-2020)
Table 35. North America Short Bowel Syndrome (SBS) Drugs Sales by Type (2015-2020) (K Pcs)
Table 36. North America Short Bowel Syndrome (SBS) Drugs Sales Market Share by Type (2015-2020)
Table 37. North America Short Bowel Syndrome (SBS) Drugs Sales by Application (2015-2020) (K Pcs)
Table 38. North America Short Bowel Syndrome (SBS) Drugs Sales Market Share by Application (2015-2020)
Table 39. Europe Short Bowel Syndrome (SBS) Drugs Sales by Country (2015-2020) (K Pcs)
Table 40. Europe Short Bowel Syndrome (SBS) Drugs Sales Market Share by Country (2015-2020)
Table 41. Europe Short Bowel Syndrome (SBS) Drugs Revenue by Country (2015-2020) (US$ Million)
Table 42. Europe Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Country (2015-2020)
Table 43. Europe Short Bowel Syndrome (SBS) Drugs Sales by Type (2015-2020) (K Pcs)
Table 44. Europe Short Bowel Syndrome (SBS) Drugs Sales Market Share by Type (2015-2020)
Table 45. Europe Short Bowel Syndrome (SBS) Drugs Sales by Application (2015-2020) (K Pcs)
Table 46. Europe Short Bowel Syndrome (SBS) Drugs Sales Market Share by Application (2015-2020)
Table 47. Asia Pacific Short Bowel Syndrome (SBS) Drugs Sales by Region (2015-2020) (K Pcs)
Table 48. Asia Pacific Short Bowel Syndrome (SBS) Drugs Sales Market Share by Region (2015-2020)
Table 49. Asia Pacific Short Bowel Syndrome (SBS) Drugs Revenue by Region (2015-2020) (US$ Million)
Table 50. Asia Pacific Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Region (2015-2020)
Table 51. Asia Pacific Short Bowel Syndrome (SBS) Drugs Sales by Type (2015-2020) (K Pcs)
Table 52. Asia Pacific Short Bowel Syndrome (SBS) Drugs Sales Market Share by Type (2015-2020)
Table 53. Asia Pacific Short Bowel Syndrome (SBS) Drugs Sales by Application (2015-2020) (K Pcs)
Table 54. Asia Pacific Short Bowel Syndrome (SBS) Drugs Sales Market Share by Application (2015-2020)
Table 55. Latin America Short Bowel Syndrome (SBS) Drugs Sales by Country (2015-2020) (K Pcs)
Table 56. Latin America Short Bowel Syndrome (SBS) Drugs Sales Market Share by Country (2015-2020)
Table 57. Latin Americaa Short Bowel Syndrome (SBS) Drugs Revenue by Country (2015-2020) (US$ Million)
Table 58. Latin America Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Country (2015-2020)
Table 59. Latin America Short Bowel Syndrome (SBS) Drugs Sales by Type (2015-2020) (K Pcs)
Table 60. Latin America Short Bowel Syndrome (SBS) Drugs Sales Market Share by Type (2015-2020)
Table 61. Latin America Short Bowel Syndrome (SBS) Drugs Sales by Application (2015-2020) (K Pcs)
Table 62. Latin America Short Bowel Syndrome (SBS) Drugs Sales Market Share by Application (2015-2020)
Table 63. Middle East and Africa Short Bowel Syndrome (SBS) Drugs Sales by Country (2015-2020) (K Pcs)
Table 64. Middle East and Africa Short Bowel Syndrome (SBS) Drugs Sales Market Share by Country (2015-2020)
Table 65. Middle East and Africa Short Bowel Syndrome (SBS) Drugs Revenue by Country (2015-2020) (US$ Million)
Table 66. Middle East and Africa Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Country (2015-2020)
Table 67. Middle East and Africa Short Bowel Syndrome (SBS) Drugs Sales by Type (2015-2020) (K Pcs)
Table 68. Middle East and Africa Short Bowel Syndrome (SBS) Drugs Sales Market Share by Type (2015-2020)
Table 69. Middle East and Africa Short Bowel Syndrome (SBS) Drugs Sales by Application (2015-2020) (K Pcs)
Table 70. Middle East and Africa Short Bowel Syndrome (SBS) Drugs Sales Market Share by Application (2015-2020)
Table 71. Merck Corporation Information
Table 72. Merck Description and Major Businesses
Table 73. Merck Short Bowel Syndrome (SBS) Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 74. Merck Product
Table 75. Merck Recent Development
Table 76. Takeda Corporation Information
Table 77. Takeda Description and Major Businesses
Table 78. Takeda Short Bowel Syndrome (SBS) Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 79. Takeda Product
Table 80. Takeda Recent Development
Table 81. Emmaus Medical Corporation Information
Table 82. Emmaus Medical Description and Major Businesses
Table 83. Emmaus Medical Short Bowel Syndrome (SBS) Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 84. Emmaus Medical Product
Table 85. Emmaus Medical Recent Development
Table 86. Ardelyx Corporation Information
Table 87. Ardelyx Description and Major Businesses
Table 88. Ardelyx Short Bowel Syndrome (SBS) Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 89. Ardelyx Product
Table 90. Ardelyx Recent Development
Table 91. Naia Pharmaceuticals Corporation Information
Table 92. Naia Pharmaceuticals Description and Major Businesses
Table 93. Naia Pharmaceuticals Short Bowel Syndrome (SBS) Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 94. Naia Pharmaceuticals Product
Table 95. Naia Pharmaceuticals Recent Development
Table 96. Nutrinia Corporation Information
Table 97. Nutrinia Description and Major Businesses
Table 98. Nutrinia Short Bowel Syndrome (SBS) Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 99. Nutrinia Product
Table 100. Nutrinia Recent Development
Table 101. OxThera Corporation Information
Table 102. OxThera Description and Major Businesses
Table 103. OxThera Short Bowel Syndrome (SBS) Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 104. OxThera Product
Table 105. OxThera Recent Development
Table 106. Sancilio Pharmaceuticals Corporation Information
Table 107. Sancilio Pharmaceuticals Description and Major Businesses
Table 108. Sancilio Pharmaceuticals Short Bowel Syndrome (SBS) Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 109. Sancilio Pharmaceuticals Product
Table 110. Sancilio Pharmaceuticals Recent Development
Table 111. Zealand Pharma Corporation Information
Table 112. Zealand Pharma Description and Major Businesses
Table 113. Zealand Pharma Short Bowel Syndrome (SBS) Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 114. Zealand Pharma Product
Table 115. Zealand Pharma Recent Development
Table 116. Global Short Bowel Syndrome (SBS) Drugs Sales Forecast by Regions (2021-2026) (K Pcs)
Table 117. Global Short Bowel Syndrome (SBS) Drugs Sales Market Share Forecast by Regions (2021-2026)
Table 118. Global Short Bowel Syndrome (SBS) Drugs Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 119. Global Short Bowel Syndrome (SBS) Drugs Revenue Market Share Forecast by Regions (2021-2026)
Table 120. North America: Short Bowel Syndrome (SBS) Drugs Sales Forecast by Country (2021-2026) (K Pcs)
Table 121. North America: Short Bowel Syndrome (SBS) Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 122. Europe: Short Bowel Syndrome (SBS) Drugs Sales Forecast by Country (2021-2026) (K Pcs)
Table 123. Europe: Short Bowel Syndrome (SBS) Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 124. Asia Pacific: Short Bowel Syndrome (SBS) Drugs Sales Forecast by Region (2021-2026) (K Pcs)
Table 125. Asia Pacific: Short Bowel Syndrome (SBS) Drugs Revenue Forecast by Region (2021-2026) (US$ Million)
Table 126. Latin America: Short Bowel Syndrome (SBS) Drugs Sales Forecast by Country (2021-2026) (K Pcs)
Table 127. Latin America: Short Bowel Syndrome (SBS) Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 128. Middle East and Africa: Short Bowel Syndrome (SBS) Drugs Sales Forecast by Country (2021-2026) (K Pcs)
Table 129. Middle East and Africa: Short Bowel Syndrome (SBS) Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 130. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 131. Key Challenges
Table 132. Market Risks
Table 133. Main Points Interviewed from Key Short Bowel Syndrome (SBS) Drugs Players
Table 134. Short Bowel Syndrome (SBS) Drugs Customers List
Table 135. Short Bowel Syndrome (SBS) Drugs Distributors List
Table 136. Research Programs/Design for This Report
Table 137. Key Data Information from Secondary Sources
Table 138. Key Data Information from Primary Sources
List of Figures
Figure 1. Short Bowel Syndrome (SBS) Drugs Product Picture
Figure 2. Global Short Bowel Syndrome (SBS) Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Glucagon-Like Peptide-2 (GLP-2) Product Picture
Figure 4. Growth Hormone Product Picture
Figure 5. Glutamine Product Picture
Figure 6. Other Product Picture
Figure 7. Global Short Bowel Syndrome (SBS) Drugs Sales Market Share by Application in 2020 & 2026
Figure 8. Hospitals
Figure 9. Clinics
Figure 10. Retail Pharmacies
Figure 11. Short Bowel Syndrome (SBS) Drugs Report Years Considered
Figure 12. Global Short Bowel Syndrome (SBS) Drugs Market Size 2015-2026 (US$ Million)
Figure 13. Global Short Bowel Syndrome (SBS) Drugs Sales 2015-2026 (K Pcs)
Figure 14. Global Short Bowel Syndrome (SBS) Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Global Short Bowel Syndrome (SBS) Drugs Sales Market Share by Region (2015-2020)
Figure 16. Global Short Bowel Syndrome (SBS) Drugs Sales Market Share by Region in 2019
Figure 17. Global Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Region (2015-2020)
Figure 18. Global Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Region in 2019
Figure 19. Global Short Bowel Syndrome (SBS) Drugs Sales Share by Manufacturer in 2019
Figure 20. The Top 10 and 5 Players Market Share by Short Bowel Syndrome (SBS) Drugs Revenue in 2019
Figure 21. Short Bowel Syndrome (SBS) Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 22. Global Short Bowel Syndrome (SBS) Drugs Sales Market Share by Type (2015-2020)
Figure 23. Global Short Bowel Syndrome (SBS) Drugs Sales Market Share by Type in 2019
Figure 24. Global Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Type (2015-2020)
Figure 25. Global Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Type in 2019
Figure 26. Global Short Bowel Syndrome (SBS) Drugs Market Share by Price Range (2015-2020)
Figure 27. Global Short Bowel Syndrome (SBS) Drugs Sales Market Share by Application (2015-2020)
Figure 28. Global Short Bowel Syndrome (SBS) Drugs Sales Market Share by Application in 2019
Figure 29. Global Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Application (2015-2020)
Figure 30. Global Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Application in 2019
Figure 31. North America Short Bowel Syndrome (SBS) Drugs Sales Growth Rate 2015-2020 (K Pcs)
Figure 32. North America Short Bowel Syndrome (SBS) Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 33. North America Short Bowel Syndrome (SBS) Drugs Sales Market Share by Country in 2019
Figure 34. North America Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Country in 2019
Figure 35. U.S. Short Bowel Syndrome (SBS) Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 36. U.S. Short Bowel Syndrome (SBS) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Canada Short Bowel Syndrome (SBS) Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 38. Canada Short Bowel Syndrome (SBS) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. North America Short Bowel Syndrome (SBS) Drugs Market Share by Type in 2019
Figure 40. North America Short Bowel Syndrome (SBS) Drugs Market Share by Application in 2019
Figure 41. Europe Short Bowel Syndrome (SBS) Drugs Sales Growth Rate 2015-2020 (K Pcs)
Figure 42. Europe Short Bowel Syndrome (SBS) Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 43. Europe Short Bowel Syndrome (SBS) Drugs Sales Market Share by Country in 2019
Figure 44. Europe Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Country in 2019
Figure 45. Germany Short Bowel Syndrome (SBS) Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 46. Germany Short Bowel Syndrome (SBS) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. France Short Bowel Syndrome (SBS) Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 48. France Short Bowel Syndrome (SBS) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. U.K. Short Bowel Syndrome (SBS) Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 50. U.K. Short Bowel Syndrome (SBS) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Italy Short Bowel Syndrome (SBS) Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 52. Italy Short Bowel Syndrome (SBS) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Russia Short Bowel Syndrome (SBS) Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 54. Russia Short Bowel Syndrome (SBS) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Europe Short Bowel Syndrome (SBS) Drugs Market Share by Type in 2019
Figure 56. Europe Short Bowel Syndrome (SBS) Drugs Market Share by Application in 2019
Figure 57. Asia Pacific Short Bowel Syndrome (SBS) Drugs Sales Growth Rate 2015-2020 (K Pcs)
Figure 58. Asia Pacific Short Bowel Syndrome (SBS) Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 59. Asia Pacific Short Bowel Syndrome (SBS) Drugs Sales Market Share by Region in 2019
Figure 60. Asia Pacific Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Region in 2019
Figure 61. China Short Bowel Syndrome (SBS) Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 62. China Short Bowel Syndrome (SBS) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Japan Short Bowel Syndrome (SBS) Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 64. Japan Short Bowel Syndrome (SBS) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. South Korea Short Bowel Syndrome (SBS) Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 66. South Korea Short Bowel Syndrome (SBS) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. India Short Bowel Syndrome (SBS) Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 68. India Short Bowel Syndrome (SBS) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Australia Short Bowel Syndrome (SBS) Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 70. Australia Short Bowel Syndrome (SBS) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Taiwan Short Bowel Syndrome (SBS) Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 72. Taiwan Short Bowel Syndrome (SBS) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Indonesia Short Bowel Syndrome (SBS) Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 74. Indonesia Short Bowel Syndrome (SBS) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Thailand Short Bowel Syndrome (SBS) Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 76. Thailand Short Bowel Syndrome (SBS) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Malaysia Short Bowel Syndrome (SBS) Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 78. Malaysia Short Bowel Syndrome (SBS) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Philippines Short Bowel Syndrome (SBS) Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 80. Philippines Short Bowel Syndrome (SBS) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Vietnam Short Bowel Syndrome (SBS) Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 82. Vietnam Short Bowel Syndrome (SBS) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Asia Pacific Short Bowel Syndrome (SBS) Drugs Market Share by Type in 2019
Figure 84. Asia Pacific Short Bowel Syndrome (SBS) Drugs Market Share by Application in 2019
Figure 85. Latin America Short Bowel Syndrome (SBS) Drugs Sales Growth Rate 2015-2020 (K Pcs)
Figure 86. Latin America Short Bowel Syndrome (SBS) Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 87. Latin America Short Bowel Syndrome (SBS) Drugs Sales Market Share by Country in 2019
Figure 88. Latin America Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Country in 2019
Figure 89. Mexico Short Bowel Syndrome (SBS) Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 90. Mexico Short Bowel Syndrome (SBS) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Brazil Short Bowel Syndrome (SBS) Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 92. Brazil Short Bowel Syndrome (SBS) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Argentina Short Bowel Syndrome (SBS) Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 94. Argentina Short Bowel Syndrome (SBS) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Latin America Short Bowel Syndrome (SBS) Drugs Market Share by Type in 2019
Figure 96. Latin America Short Bowel Syndrome (SBS) Drugs Market Share by Application in 2019
Figure 97. Middle East and Africa Short Bowel Syndrome (SBS) Drugs Sales Growth Rate 2015-2020 (K Pcs)
Figure 98. Middle East and Africa Short Bowel Syndrome (SBS) Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 99. Middle East and Africa Short Bowel Syndrome (SBS) Drugs Sales Market Share by Country in 2019
Figure 100. Middle East and Africa Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Country in 2019
Figure 101. Turkey Short Bowel Syndrome (SBS) Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 102. Turkey Short Bowel Syndrome (SBS) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. Saudi Arabia Short Bowel Syndrome (SBS) Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 104. Saudi Arabia Short Bowel Syndrome (SBS) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. U.A.E Short Bowel Syndrome (SBS) Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 106. U.A.E Short Bowel Syndrome (SBS) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. Middle East and Africa Short Bowel Syndrome (SBS) Drugs Market Share by Type in 2019
Figure 108. Middle East and Africa Short Bowel Syndrome (SBS) Drugs Market Share by Application in 2019
Figure 109. North America Short Bowel Syndrome (SBS) Drugs Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 110. North America Short Bowel Syndrome (SBS) Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 111. Europe Short Bowel Syndrome (SBS) Drugs Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 112. Europe Short Bowel Syndrome (SBS) Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Asia Pacific Short Bowel Syndrome (SBS) Drugs Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 114. Asia Pacific Short Bowel Syndrome (SBS) Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Latin America Short Bowel Syndrome (SBS) Drugs Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 116. Latin America Short Bowel Syndrome (SBS) Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Middle East and Africa Short Bowel Syndrome (SBS) Drugs Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 118. Middle East and Africa Short Bowel Syndrome (SBS) Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Porter's Five Forces Analysis
Figure 120. Channels of Distribution
Figure 121. Distributors Profiles
Figure 122. Bottom-up and Top-down Approaches for This Report
Figure 123. Data Triangulation
Figure 124. Key Executives Interviewed

---